1. FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease. (22nd October 2019) Authors: Przepiorka, Donna; Luo, Lola; Subramaniam, Sriram; Qiu, Junshan; Gudi, Ramadevi; Cunningham, Lea C.; Nie, Lei; Leong, Ruby; Ma, Lian; Sheth, Christopher; Deisseroth, Albert; Goldberg, Kirsten B.; Blumenthal, Gideon M.; Pazdur, Richard Journal: Oncologist Issue: Volume 25:Number 2(2020) Page Start: e328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗